Literature DB >> 20924395

A splicing mastermind for EMT.

Joao P Tavanez1, Juan Valcárcel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20924395      PMCID： PMC2957219          DOI： 10.1038/emboj.2010.234

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  10 in total

1.  An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition.

Authors:  Claude C Warzecha; Peng Jiang; Karine Amirikian; Kimberly A Dittmar; Hezhe Lu; Shihao Shen; Wei Guo; Yi Xing; Russ P Carstens
Journal:  EMBO J       Date:  2010-08-13       Impact factor: 11.598

Review 2.  Complex networks orchestrate epithelial-mesenchymal transitions.

Authors:  Jean Paul Thiery; Jonathan P Sleeman
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

3.  STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo.

Authors:  Genta Ohno; Masatoshi Hagiwara; Hidehito Kuroyanagi
Journal:  Genes Dev       Date:  2008-01-29       Impact factor: 11.361

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 5.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.

Authors:  Mo Chen; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-23       Impact factor: 94.444

6.  Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB.

Authors:  Miriam Llorian; Schraga Schwartz; Tyson A Clark; Dror Hollander; Lit-Yeen Tan; Rachel Spellman; Adele Gordon; Anthony C Schweitzer; Pierre de la Grange; Gil Ast; Christopher W J Smith
Journal:  Nat Struct Mol Biol       Date:  2010-08-15       Impact factor: 15.369

7.  ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.

Authors:  Claude C Warzecha; Trey K Sato; Behnam Nabet; John B Hogenesch; Russ P Carstens
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

Review 8.  RNA binding protein sex-lethal (Sxl) and control of Drosophila sex determination and dosage compensation.

Authors:  Luiz O F Penalva; Lucas Sánchez
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

9.  An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells.

Authors:  Gene W Yeo; Nicole G Coufal; Tiffany Y Liang; Grace E Peng; Xiang-Dong Fu; Fred H Gage
Journal:  Nat Struct Mol Biol       Date:  2009-01-11       Impact factor: 15.369

10.  HITS-CLIP yields genome-wide insights into brain alternative RNA processing.

Authors:  Donny D Licatalosi; Aldo Mele; John J Fak; Jernej Ule; Melis Kayikci; Sung Wook Chi; Tyson A Clark; Anthony C Schweitzer; John E Blume; Xuning Wang; Jennifer C Darnell; Robert B Darnell
Journal:  Nature       Date:  2008-11-02       Impact factor: 49.962
  10 in total
  8 in total

Review 1.  Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.

Authors:  Paola Nisticò; Mina J Bissell; Derek C Radisky
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Misu Lee; Jeong Yong Jeon; Micheal L Neugent; Jung-Whan Kim; Mijin Yun
Journal:  Clin Exp Metastasis       Date:  2017-04-20       Impact factor: 5.150

3.  Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonization.

Authors:  Zhi-xiang Lu; Qin Huang; Juw Won Park; Shihao Shen; Lan Lin; Collin J Tokheim; Michael D Henry; Yi Xing
Journal:  Mol Cancer Res       Date:  2014-10-01       Impact factor: 5.852

4.  Novel insights into breast cancer genetic variance through RNA sequencing.

Authors:  Anelia Horvath; Suresh Babu Pakala; Prakriti Mudvari; Sirigiri Divijendra Natha Reddy; Kazufumi Ohshiro; Sandra Casimiro; Ricardo Pires; Suzanne A W Fuqua; Masakazu Toi; Luis Costa; Sujit S Nair; Saraswati Sukumar; Rakesh Kumar
Journal:  Sci Rep       Date:  2013       Impact factor: 4.996

5.  Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.

Authors:  Pietro Fici; Giulia Gallerani; Anne-Pierre Morel; Laura Mercatali; Toni Ibrahim; Emanuela Scarpi; Dino Amadori; Alain Puisieux; Michel Rigaud; Francesco Fabbri
Journal:  Oncotarget       Date:  2017-01-10

6.  The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia.

Authors:  Hanhee Jo; Jongsook Lee; Jeongyong Jeon; Seon Yoo Kim; Jee-In Chung; Hae Yong Ko; Misu Lee; Mijin Yun
Journal:  Sci Rep       Date:  2020-01-30       Impact factor: 4.379

7.  Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.

Authors:  Morton Freytag; Martina Kluth; Elena Bady; Claudia Hube-Magg; Georgia Makrypidi-Fraune; Hans Heinzer; Doris Höflmayer; Sören Weidemann; Ria Uhlig; Hartwig Huland; Markus Graefen; Christian Bernreuther; Corinna Wittmer; Maria Christina Tsourlakis; Sarah Minner; David Dum; Andrea Hinsch; Andreas M Luebke; Ronald Simon; Guido Sauter; Thorsten Schlomm; Katharina Möller
Journal:  BMC Cancer       Date:  2020-12-18       Impact factor: 4.430

Review 8.  Therapeutic strategies targeting cancer stem cells.

Authors:  Go J Yoshida; Hideyuki Saya
Journal:  Cancer Sci       Date:  2015-10-21       Impact factor: 6.716
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.